226 related articles for article (PubMed ID: 2861411)
1. Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.
Yates AJ; Percival RC; Gray RE; Atkins RM; Urwin GH; Hamdy NA; Preston CJ; Beneton MN; Russell RG; Kanis JA
Lancet; 1985 Jun; 1(8444):1474-7. PubMed ID: 2861411
[TBL] [Abstract][Full Text] [Related]
2. Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone.
Meunier PJ; Chapuy MC; Alexandre C; Bressot C; Edouard C; Vignon C; Mathieu L; Trechsel U
Lancet; 1979 Sep; 2(8141):489-92. PubMed ID: 90215
[TBL] [Abstract][Full Text] [Related]
3. Paget's disease of bone: benefits of neridonate as a first treatment and in cases of relapse after clodronate.
Filipponi P; Cristallini S; Policani G; Casciari C; Gregorio F
Bone; 1998 Dec; 23(6):543-8. PubMed ID: 9855463
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate.
Adami S; Salvagno G; Guarrera G; Montesanti F; Garavelli S; Rosini S; Lo Cascio V
Calcif Tissue Int; 1986 Oct; 39(4):226-9. PubMed ID: 2947663
[TBL] [Abstract][Full Text] [Related]
5. Duration of effect of oral diphosphonate therapy in Paget's disease of bone.
Gray RE; Yates AJ; Preston CJ; Smith R; Russell RG; Kanis JA
Q J Med; 1987 Sep; 64(245):755-67. PubMed ID: 2966965
[TBL] [Abstract][Full Text] [Related]
6. Aminohexane diphosphonate in the treatment of Paget's disease of bone.
Atkins RM; Yates AJ; Gray RE; Urwin GH; Hamdy NA; Beneton MN; Rosini S; Kanis JA
J Bone Miner Res; 1987 Aug; 2(4):273-9. PubMed ID: 3455614
[TBL] [Abstract][Full Text] [Related]
7. Duration of response with oral clodronate in Paget's disease of bone.
Khan SA; McCloskey EV; Nakatsuka K; Orgee J; Coombes GM; Kanis JA
Bone; 1996 Feb; 18(2):185-90. PubMed ID: 8833213
[TBL] [Abstract][Full Text] [Related]
8. Effects of two different bisphosphonates on Paget's disease of bone: ICTP assessed.
Filipponi P; Pedetti M; Beghe F; Giovagnini B; Miam M; Cristallini S
Bone; 1994; 15(3):261-7. PubMed ID: 8068446
[TBL] [Abstract][Full Text] [Related]
9. Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
Harinck HI; Bijvoet OL; Blanksma HJ; Dahlinghaus-Nienhuys PJ
Clin Orthop Relat Res; 1987 Apr; (217):79-98. PubMed ID: 2951049
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone.
Douglas DL; Duckworth T; Kanis JA; Preston C; Beard DJ; Smith TW; Underwood I; Woodhead JS; Russell RG
Arthritis Rheum; 1980 Oct; 23(10):1185-92. PubMed ID: 6448604
[TBL] [Abstract][Full Text] [Related]
11. Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.
Chapuy MC; Charhon SA; Meunier PJ
Metab Bone Dis Relat Res; 1983; 4(6):325-8. PubMed ID: 6229683
[TBL] [Abstract][Full Text] [Related]
12. Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
Douglas DL; Duckworth T; Russell RG; Kanis JA; Preston CJ; Preston FE; Prenton MA; Woodhead JS
Lancet; 1980 May; 1(8177):1043-7. PubMed ID: 6103389
[TBL] [Abstract][Full Text] [Related]
13. Short courses of intravenous clodronate in the treatment of Paget's disease of bone: a long-term follow-up trial.
Broggini M; Baratelli E; Cappelli A; Marconi A; Ghiringhelli D; Salzillo A
Int J Clin Pharmacol Res; 1993; 13(6):301-4. PubMed ID: 8088930
[TBL] [Abstract][Full Text] [Related]
14. Long term effects of dichloromethylene diphosphonate in Paget's disease of bone.
Delmas PD; Chapuy MC; Vignon E; Charhon S; Briancon D; Alexandre C; Edouard C; Meunier PJ
J Clin Endocrinol Metab; 1982 Apr; 54(4):837-44. PubMed ID: 6460781
[TBL] [Abstract][Full Text] [Related]
15. Effects of disodium dichloromethylene diphosphonate (CL2MDP) on Paget's disease of bone.
Meunier PJ; Chapuy MC; Alexandre C; Bressot C; Vignon E; Trechsel U; Mathieu L; Edouard C
Adv Exp Med Biol; 1980; 128():299-309. PubMed ID: 6448538
[No Abstract] [Full Text] [Related]
16. Sequential treatment of Paget's disease with human calcitonin and dichloromethylene diphosphonate (Cl2MDP).
Adami S; Guarrera G; Salvagno G; Spiazzi G; Marini G; Rosini S; Lo Cascio V
Metab Bone Dis Relat Res; 1984; 5(6):265-7. PubMed ID: 6238218
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of an antiviral drug, inosiplex, and diphosphonates in Paget's disease of bone.
Kanis JA; Preston CJ; Beard DJ; Beneton M; Harris S; Russell RG
Bone; 1985; 6(2):69-72. PubMed ID: 2409999
[TBL] [Abstract][Full Text] [Related]
18. Improvement in the deformity of the face in Paget's disease treated with diphosphonates.
Bickerstaff DR; Douglas DL; Burke PH; O'Doherty DP; Kanis JA
J Bone Joint Surg Br; 1990 Jan; 72(1):132-6. PubMed ID: 2137127
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate.
Delmas PD; Chapuy MC; Meunier PJ
Horm Metab Res; 1984 May; 16(5):258-61. PubMed ID: 6234216
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic strategy in Paget's disease of bone.
Meunier PJ; Vignot E
Bone; 1995 Nov; 17(5 Suppl):489S-491S. PubMed ID: 8573424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
